Ketesse, Injektions-/Infusionslösung

7680560590024 CH-56059 Ampullen
Ketesse, Injektions-/Infusionslösung
Ketesse, Injektions-/Infusionslösung
Ketesse, Injektions-/Infusionslösung
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Ampulle(n)
Galenic form
Ampullen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/10/2025
Summary of Product Characteristics
Français
13/10/2025
Summary of Product Characteristics
Italien
13/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
73.8 MG Substance WIZUS
(N/A)
200.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.15 MG Substance HBESI

Reimbursement information

Public price
CHF 13.85
Specialties list
Yes
Generic
No
SL addition date: 01/08/2004

Authorization holder

A. Menarini GmbH

8050 Zürich

Authorization information

Swissmedic authorization number
56059
Drug name
Ketesse, Injektions-/Infusionslösung
Galenic form
LSPA
ATC Code
M01AE17
Authorization status
Z
Dispensing category
B
First authorization
28/05/2004
Authorization expiration date
31/12/9999
IT Number
07.10.1.
Domain
Human medicine
Field of application
Nichtsteroidales Analgetikum/Antirheumatikum

Package details

Description (FR)
KETESSE sol inj 50 mg/2ml 5 amp 2 ml
Description (DE)
KETESSE Inj Lös 50 mg/2ml 5 Amp 2 ml
Market launch
28/05/2004
Narcotic (BTM)
No

Other package sizes (2)

KETESSE sol inj 50 mg/2ml 20 amp 2 ml
20 AMP
GTIN: 7680560590048
View
None
None None
GTIN: None
Not in V1